70 results about "Herba Scutellariae Barbatae" patented technology

A traditional Chinese medicine composition for treating pulmonary nodules, wherein the composition is prepared from the following traditional Chinese medicines in parts by weight: a principle drug selected from one or more of 10-45 parts of raw Astragali radix, 10-25 parts of Sargassum, and 10-25 parts of Arisaematis rhizoma preparatum; a minister drug selected from one or more of 10-25 parts of Fritillariae thunbergii bulbus, 10-25 parts of Forsythiae fructus, 10-25 parts of stir-fried Atractylodis macrocephalae rhizoma, 1T0 part of Hirudo, 10-25 parts of Dioscoreae nipponicae rhizoma, 10-35 parts of Adenophorae radix, 10-35 parts of honey-processed Mori cortex, 10-25 parts of Perillae fructus, 10-25 parts of Peucedani radix, 10-35 parts of Phragmitis rhizome, 10-45 parts of raw Coicis semen, 5-25 parts of vinegar-processed Cyperi rhizoma, 10-25 parts of Aurantii fructus, 10-25 parts of Paeoniae radix alba, 10-35 parts of Scutellariae barbatae herba, 10-35 parts of Herba duchesneae indicae, 10-35 parts of Salviae chinensis herba, 5-20 parts of Menispermi rhizoma, 5-20 parts of Momordicae semen, 10-25 parts of Curcumae rhizoma, and 5-20 parts of Gleditsiae spina; an assistant drug selected from one or more of 5-25 parts of vinegar-processed Bupleuri radix, 5-25 parts of Citri reticulatae pericarpium, 10-25 parts of Perillae fructus, 2-12 parts of processed Ephedrae herba, 10-25 parts of Cynanchi stauntonii rhizoma et radix, 5-20 parts of Typhonii rhizoma, 2-12 parts of Zingiberis rhizoma, 10-35 parts of Morindae officinalis radix, 10-35 parts of Scutellariae barbatae herba, 10-45 parts of Radix aconiti lateralis praeparata nigra, and 10-25 parts of Typhonii rhizoma praeparata; and an envoy drug selected from one or more of 5-20 parts of Fagopyri dibotryis rhizoma, 10-25 parts of Platycodonis radix, 10-25 parts of Paeoniae radix alba, and 5-25 parts of Glycyrrhizae radix et rhizoma praeparata cum melle.

The invention belongs to the technical field of biological medicines, and particularly relates to a traditional Chinese medicine composition for treating metabolism-related fatty liver diseases and a preparation method thereof. The technical problem to be solved by the invention is to provide a new choice for treating metabolism-related fatty liver diseases. According to the technical scheme, the traditional Chinese medicine composition for treating the metabolism-related fatty liver disease is prepared from the following components: radix paeoniae rubra, cyrtomium fortunei, curcuma zedoary, sculellaria barbata, herba epimedii, fingered citron, semen cassiae and herba artemisiae scopariae. The invention is mainly used for providing a new choice for treating the metabolism-related fatty liver disease, and has a wide application prospect.

The invention belongs to the technical field of veterinary drug compositions, and particularly relates to a veterinary drug composition containing traditional Chinese medicine ingredients, which comprises the following raw materials in variety and proportion: 8-15 parts of honeysuckle, 3-6 parts of fructus forsythiae, 6-9 parts of coptis chinensis, 12-20 parts of chrysanthemum, 6-8 parts of semen plantaginis, 7-10 parts of lygodium japonicum, 6-10 parts of houttuynia cordata, 10-13 parts of radix bupleuri, 3-7 parts of pseudo-ginseng, 6-12 parts of salvia miltiorrhiza, 6-8 parts of subprostrate sophora and 12-20 parts of sculellaria barbata. According to the veterinary medicine composition containing the traditional Chinese medicine components, by selecting honeysuckle, fructus forsythiae, coptis chinensis, chrysanthemum, semen plantaginis, lygodium japonicum, houttuynia cordata, radix bupleuri, pseudo-ginseng, salvia miltiorrhiza, subprostrate sophora and sculellaria barbata, the effects of clearing away heat and toxic materials, stopping diarrhea and dysentery, cooling blood and dispelling wind, nourishing yin and moistening dryness, strengthening the body resistance to eliminate pathogenic factors and expelling and killing insects of the composition can be guaranteed; and by arranging the stabilizer, the cosolvent and the preservative, the state stability and the service life of the composition can be guaranteed.

The invention discloses a preparation method of a medicine for treating kidney diseases. The medicine comprises the following raw materials in parts by weight: 10-15 parts of astragalus membranaceus, 8-12 parts of salvia miltiorrhiza, 6-10 parts of angelica sinensis, 3-5 parts of cinnamon, 4-8 parts of safflower carthamus, 6-10 parts of bamboo leaves, 8-12 parts of artemisia apiacea, 4-6 parts of junci medulla, 6-10 parts of sculellaria barbata, 6-20 parts of pyrrosia lingua, 5-10 parts of honeysuckle, 6-12 parts of fructus forsythiae, 8-15 parts of poria cocos, 4-6 parts of liquorice, 4-6 parts of radix angelicae pubescentis, 4-6 parts of radix ginseng rubra, 4-6 parts of decaisnea insignis and 4-6 parts of Qianju. , 4-6 parts of Chinese yam, 4-6 parts of turtle shell and 4-6 parts of burdock; the traditional Chinese medicine composition has the beneficial effects that the medicine formula is more optimized, various Chinese herbal medicine raw materials with the effects of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis and the like are selected, and the curative effect and safety of the medicine are improved through scientific compatibility; the preparation method is more perfect, and effective components in the Chinese herbal medicines are effectively extracted through the steps of crushing, decocting, concentrating, drying and the like.

The use of a Reyanning formulation in the preparation of a drug for preventing and treating prostatitis. The Reyanning formulation is prepared from dandelion, giant knotweed rhizome, sonchi arvensis herba and herba scutellariae barbatae. The present application finds that the Reyanning formulation can reduce the contents of IL-6, IL-1β, NO and MDA in the serum of model rats, HE staining results show that the Reyanning formulation has certain relieving effect on the damage of prostate tissue, and it can be concluded from the molecular and tissue levels that the Reyanning formulation has certain prevention and treatment effect on chronic non-bacterial prostatitis.

The invention relates to the technical field of cordyceps sinensis, and particularly discloses cordyceps sinensis sporocarp electuary as well as a preparation method and application thereof. The medicinal material formula of the cordyceps sinensis sporocarp electuary is prepared from the following raw materials by weight: 35 to 45 g of cordyceps sinensis sporocarp powder, 16 to 22 g of radix ophiopogonis, 15 to 20 g of radix asparagi, 10 to 15 g of radix glehniae, 10 to 15 g of radix adenophorae, 25 to 35 g of rhizoma polygonati, 26 to 32 g of radix astragali seu hedysari, 10 to 15 g of radix angelicae sinensis, 25 to 34 g of caulis spatholobi, 25 to 30 g of solanum lyratum, 15 to 25 g of herba scutellariae barbatae, 25 to 30 g of oldenlandia diffusa, 25 to 35 g of salvia chinensis, 25 to 30 g of raw malt, 25 to 30 g of rice sprout, 25 to 30 g of medicated leaven and 8 to 12 g of periostracum cicadae. The cordyceps sinensis sporocarp electuary can be used for treating lung cancer, and has the advantages of strengthening the body resistance, resisting cancer and decomposing tumors.

The invention provides a traditional Chinese medicine composition, a preparation method and application thereof and a pharmaceutical composition. The traditional Chinese medicine composition comprises radix pseudostellariae, astragalus membranaceus, sculellaria barbata, houttuynia cordata, radix bupleuri, semen coicis, rhizoma polygonati, platycodon grandiflorum and liquorice. The traditional Chinese medicine composition provided by the invention is high in safety, long in application period, outstanding in immune regulation function, low in drug resistance risk, remarkable in comprehensive curative effect, wide in adaptation disease range and flexible in clinical application, and multiple mechanisms are cooperated.

The invention discloses a traditional Chinese medicine composition for treating constipation as well as a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The composition comprises the following components in parts by weight: 45 to 85 parts of Chinese pulsatilla root, 45 to 85 parts of oldenlandia diffusa, 45 to 85 parts of sculellaria barbata, 80 to 140 parts of Chinese actinidia root, 45 to 85 parts of trogopterus dung, 80 to 140 parts of coix seed, 80 to 140 parts of poria cocos, 80 to 140 parts of rhizoma pinellinae praeparata, 45 to 85 parts of pericarpium citri reticulatae, 60 to 100 parts of bighead atractylodes rhizome, 45 to 85 parts of endothelium corneum gigeriae galli, 60 to 100 parts of white hyacinth bean, 60 to 100 parts of dried ginger and 45 to 85 parts of liquorice. The traditional Chinese medicine composition has a good treatment effect on constipation caused by gastrointestinal tumors, is mild in medicine property, and is specially developed for patients with constipation caused by tumors.

A pharmaceutical composition for treating helicobacter pylori infectious stomach disease belongs to the technical field of medicine, and comprises the following raw materials by weight: 5-30 g of adenophora stricta, 10-30 g of hairyvein agrimony, 10-30 g of fried coix seed, 5-20 g of lily, 10-20 g of oldenlandia diffusa, 5-30 g of pericarpium citri reticulatae, 5-20 g of bighead atractylodes rhizome, 5-30 g of dandelion, 10-30 g of sculellaria barbata, and 5-30 g of scutellaria baicalensis. By soothing liver and regulating qi, clearing heat and harmonizing stomach, strengthening spleen and calming middle-jiao and taking both symptoms and root causes into consideration, the medicine makes up the deficiency of western medicines, and pays attention to enhancing the defense function of the body, protecting the gastric mucosal barrier and correcting the gastrointestinal tract function while eliminating helicobacter pylori infection, thereby achieving the purposes of strengthening body resistance and expelling evil. The spleen-tonifying and detoxifying decoction is combined with western medicines to remarkably improve the eradication rate of helicobacter pylori, improve symptoms and relieve the side effects of the western medicines, and has the advantages of quick response, high effective rate, definite curative effect, short treatment course, no toxic or side effect, low price and the like.

The invention discloses a herbal nose-soothing health-care liquid and a preparation method thereof, and particularly relates to the technical field of rhinitis medicine preparation, and the herbal nose-soothing health-care liquid comprises the following components in parts by weight: 5-15 parts of angelica sinensis, 5-15 parts of salvia miltiorrhiza, 5-15 parts of ligusticum wallichii, 5-15 parts of sculellaria barbata, 5-15 parts of sambucus williamsii, 5-15 parts of pseudo-ginseng, 3-10 parts of magnolia flower, 3-10 parts of centipeda minima, 10-20 parts of astragalus membranaceus and 1-3 parts of borneol. According to the preparation method, medicinal materials with different properties are subjected to grouping treatment, graded extraction of components with different polarities is achieved through gradient variable-pressure decoction, the yield of active components is increased and the flavor of the product is improved through ultrasonic-assisted enzymolysis and solid-state segmented fermentation, accurate enrichment of target components is achieved through a membrane separation and resin adsorption combined technology, and the purity of the product is improved. The stability of volatile components is remarkably improved through a cyclodextrin inclusion technology, and the preparation is ensured to be uniformly dispersed through a high-shear emulsification technology.

The invention discloses a traditional Chinese medicine composition for treating metabolic dysfunction related steatohepatitis inflammatory cancer transformation. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 15-20 parts of fructus perillae, 12-18 parts of semen brassicae, 12-18 parts of semen raphani, 12-18 parts of radix astragali, 28-32 parts of herba scutellariae barbatae, 12-18 parts of rhizoma polygonati, 6-12 parts of gecko, 12-18 parts of radix polygoni multiflori and 4-8 parts of liquorice root. The traditional Chinese medicine composition disclosed by the invention can be used for inhibiting the transformation progress of mouse metabolic dysfunction related steatohepatitis cancer, reducing the number of liver tumors, reducing the maximum surface area of the tumors and reducing the mRNA (messenger ribonucleic acid) levels of related tumor markers Gpc3 and Ly6d. In addition, the lipid level of the mouse liver and serum can be remarkably reduced, the fatty degeneration degree of the mouse liver is improved, the ALT and AST levels of the serum are reduced, and liver injury is relieved. In addition, the invention further discloses medical application of the traditional Chinese medicine composition.

The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating tumors and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 3 to 6 parts of traditional Chinese medicine extract, 5 to 10 parts of modified SiO2 and 8 to 12 parts of cellulose-chitosan compound, the traditional Chinese medicine extract is prepared from the following raw material components: 20 to 30 parts of herba scutellariae barbatae, 20 to 30 parts of herba hedyotidis diffusae, 15 to 25 parts of radix astragali seu hedysari, 10 to 20 parts of radix codonopsis, 10 to 15 parts of radix notoginseng and 5 to 10 parts of radix glycyrrhizae. The prepared traditional Chinese medicine composition can effectively inhibit tumor growth and has high biological safety and bioavailability.

This invention belongs to the field of gastric disease treatment, specifically relating to a traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia and its preparation method. The traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia comprises the following raw materials in parts by weight: Agrimonia pilosa 10-15 parts, Cyperus rotundus 8-10 parts, Scutellaria barbata 10-15 parts, Lobelia chinensis 10-15 parts, Patrinia scabiosaefolia 13-17 parts, Scutellaria baicalensis 7-11 parts, Hedyotis diffusa 10-15 parts, Prunella vulgaris 10-15 parts, Hedyotis diffusa 5-7 parts, Perilla frutescens 8-10 parts, Coptis chinensis 5-7 parts, Angelica sinensis 5-7 parts, etc. This invention focuses on the core pathogenesis of damp-heat in the spleen and stomach and stagnation of gastric collaterals. The Chinese herbal composition has the effects of clearing heat and removing dampness, regulating qi and harmonizing the stomach, nourishing blood and unblocking collaterals. Clinically, it can significantly improve the OLGA / OLGIM stage of patients with chronic atrophic gastritis with intestinal metaplasia, with a total effective rate of 65.1%, providing a safe and effective Chinese medicine solution for precancerous lesions of the stomach.

This invention discloses a traditional Chinese medicine composition for treating liver fibrosis with damp-heat toxicity, comprising the following raw materials in parts by weight: 20-30 parts of processed turtle shell, 18-25 parts of Oldenlandia diffusa, 11-15 parts of Curcuma zedoaria, 20-30 parts of processed Salvia miltiorrhiza (wine-processed), 14-20 parts of Scutellaria barbata, 11-15 parts of Epimedium, 10-15 parts of Artemisia capillaris, 14-20 parts of Sedum sarmentosum, 7-10 parts of Bupleurum chinense, 7-10 parts of Curcuma longa, 6-8 parts of dried ginger, 11-15 parts of stir-fried Atractylodes macrocephala, 18-25 parts of Astragalus membranaceus, 7-10 parts of Prunus persica, 8-12 parts of Schisandra chinensis, 4-6 parts of Panax notoginseng (powder), 14-20 parts of Poria cocos, and 3-5 parts of Cinnamomum cassia. This traditional Chinese medicine composition is developed based on the principles of TCM syndrome differentiation and treatment for liver fibrosis with damp-heat toxicity, and has the expected therapeutic effect on this condition.

The invention belongs to the technical field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine for treating lung cancer and a preparation method and application thereof. The traditional Chinese medicine is prepared from the following raw materials in parts by weight through water extraction or decoction: 3-4 parts of wild buckwheat rhizome, 2-3 parts of sculellaria barbata, 2-3 parts of oldenlandia diffusa and 0.5-2 parts of pericarpium citri reticulatae. According to the traditional Chinese medicine formula, through the synergistic effect of compatibility of the raw materials, the treatment effect of the traditional Chinese medicine can be brought into play, after water extraction or decoction, the traditional Chinese medicine has the remarkable inhibition effect on lung cancer cells or lung cancer no matter at the cellular level or in the animal body, and the traditional Chinese medicine is simple in compatibility and low in cost, has the advantage of treating both symptoms and root causes of the lung cancer and has a wide application prospect. Good clinical values are realized.

The application discloses a traditional Chinese medicine composition for treating renal clear cell carcinoma and a preparation method and application thereof, and belongs to the technical field of medicines. The traditional Chinese medicine composition provided by the application comprises ginseng, astragalus, atractylodes, poria cocos, herba impatiens, oldenlandia, zedoary, dogwood fruit, ligustrum lucidum and prunella vulgaris. The traditional Chinese medicine composition provided by the application is scientific and reasonable in combination, can support healthy qi and eliminate pathogenic factors, clear heat and resolve toxins, activate blood and resolve stasis, and soften and resolve hard masses. The clinical experimental results show that the traditional Chinese medicine composition provided by the application can effectively treat renal clear cell carcinoma, and the treatment efficiency is better than that of the targeted drug sorafenib; and the medicine is safe, has no obvious toxic and side effects, and performs well in improving patient's traditional Chinese medicine syndromes, improving the quality of life and reducing the level of tumor markers. The application provides a new idea and method for treating renal clear cell carcinoma, and has significant clinical significance and important popularization value.

The application provides a traditional Chinese medicine preparation for treating diabetic nephropathy and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine pharmacy. The traditional Chinese medicine preparation is prepared from traditional Chinese medicinal materials such as angelica, eucommia ulmoides, helicteres angustifolia, broussonetia papyrifera, radix paeoniae suffruticosae, curcuma longa, dendrobium, polygonatum, radix adnati, ligustrum lucidum, ipomoea purpurea, lagerstroemia indica, kochia scoparia, haes, pyrrosia lingua and herba barbatae, and has the effects of nourishing yin and kidney, promoting blood circulation to remove meridian obstruction and clearing heat and removing dampness. The traditional Chinese medicine preparation can up-regulate the expression levels of podocin and nephrin, inhibit inflammatory mediators, improve the blood sugar, urine protein, kidney function and kidney pathological injury of DN rats, provides a new idea for the treatment of diabetic nephropathy, and has a good development and application prospect.

The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for treating oral submucosal fibrosis, a preparation method and application. Comprising the following raw material components in parts by weight: 12-18 parts of sargentgloryvine stem, 12-18 parts of honeysuckle, 10-15 parts of radix salviae miltiorrhizae, 10-15 parts of radix isatidis, 10-15 parts of radix paeoniae rubra, 4-8 parts of pseudo-ginseng, 12-18 parts of sargentgloryvine stem, 12-18 parts of sculellaria barbata, 10-15 parts of dandelion, 10-15 parts of selfheal, 10-15 parts of thunberg fritillary bulb, 6-12 parts of earthworm, 12-18 parts of rehmannia, 7-13 parts of rhizoma bletillae, 10-15 parts of cordyceps flower, 10-15 parts of radix pseudostellariae and 4-8 parts of liquorice. The effect of treating the oral submucosal fibrosis is improved.

This invention relates to a traditional Chinese medicine composition for treating primary liver cancer. The composition is made from the following raw materials in parts by weight: 25-30 parts of *Codonopsis pilosula*, 10-15 parts of *Cremastra appendiculata*, 15-20 parts of *Scutellaria barbata*, 20-25 parts of *Curcuma zedoaria*, 10-15 parts of *Polygonum cuspidatum*, and 5-10 parts of *Citrus reticulata*. This invention also provides applications of the traditional Chinese medicine composition. The "Liver-Clearing Formula" of this invention uses a combination of various traditional Chinese herbs, focusing on "damp-heat, phlegm, qi stagnation, and blood stasis." The six herbs are combined to both attack and tonify, supporting the body's resistance and eliminating pathogenic factors, aiming to achieve the goal of strengthening the body's resistance and reducing pathogenic factors, thus achieving the effects of clearing heat and dampness, promoting qi circulation, resolving phlegm, and breaking up blood stasis. This helps improve the patient's quality of life and prognosis. At the same time, the use of this traditional Chinese medicine is expected to reduce the toxicity and enhance the efficacy of Western medicine, reducing adverse reactions and achieving the best therapeutic effect.

The invention discloses traditional Chinese medicine granules for treating lung cancer and a preparation method thereof, and relates to the technical field of traditional Chinese medicine formulas. The invention discloses traditional Chinese medicine granules for treating lung cancer. The traditional Chinese medicine composition is prepared from aged black nightshade, marsdenia tenacissima, podophyllum, thunberg fritillary bulb, sculellaria barbata, oldenlandia diffusa, ganoderma applanatum, poria cocos, phellinus igniarius, honeysuckle, fructus forsythiae, dandelion, carbonized sanguisorba root, humifuse euphorbia herb, phyllanthus urinaria, folium isatidis, astragalus membranaceus, cottonrose hibiscus leaves, pericarpium trichosanthis, lance asiabell root, radix ranunculi ternati, spicate clerodendranthus herb, platycodon grandiflorum, aster, rhizoma atractylodis macrocephalae, herba cepbalanoplosis segeti, scorpio, turtle shell, radix ophiopogonis, codonopsis pilosula, radix pseudostellariae, momordica grosvenori, fig, Japanese ardisia herb and pyrrosia lingua. The traditional Chinese medicine has the effects of detoxifying, astringing to stop bleeding, astringing lung and improving symptoms, can finally reduce relapse, and is safe and reliable.

This invention belongs to the field of biopharmaceuticals and specifically discloses the preparation and application of a compound formulation of Hedyotis diffusa (5-30 parts), Scutellaria barbata (3-10 parts), Houttuynia cordata (3-6 parts), Ganoderma lucidum (2-4 parts), and astaxanthin for adjuvant tumor treatment. This compound is prepared by gradient decoction, nanoemulsification, and synergistic combination of ingredients, including Hedyotis diffusa (5-30 parts), Scutellaria barbata (3-10 parts), Houttuynia cordata (3-6 parts), Ganoderma lucidum (2-4 parts), and astaxanthin (0.5-1 parts). The combination of gradient temperature-controlled decoction and nanoemulsification (particle size 50-200 nm) significantly improves the bioavailability of heat-sensitive components (such as astaxanthin), allowing for the design of various dosage forms (tablets, capsules, and pills) to meet diverse clinical needs. Animal models have demonstrated that this compound enhances the efficacy of cytarabine and cisplatin while reducing chemotherapy toxicity (resumption of ALT / AST levels to normal). This invention combines multi-target anti-tumor and immunomodulatory properties with dosage form stability, providing an innovative solution for adjuvant tumor treatment.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition for treating tinnitus. Its ingredients include: vinegar-processed turtle shell, stir-fried jujube seed, anemarrhena rhizome, phellodendron bark, rehmannia root, white peony root, poria cocos, fleeceflower root vine, scutellaria barbata, oldenlandia diffusa, stir-fried atractylodes macrocephala, prunella vulgaris, and cicada slough. The TCM composition of this invention exhibits significant multi-dimensional beneficial effects in treating tinnitus. Compared with Western medicine treatments, it avoids the side effects such as low blood pressure, dizziness, drowsiness, and dry mouth associated with vasodilators and antidepressants, and overcomes the drawbacks of physical therapy, which only temporarily relieves symptoms and cannot cure the condition. It has the advantages of holistic conditioning and fewer side effects, providing a safe, effective, and comprehensive treatment plan for tinnitus patients, and has high clinical application value and promotional significance.

The invention provides a garter snake pain-relieving traditional Chinese medicine preparation as well as a preparation method and application thereof. The invention discloses a Zaocys dhumnades pain relieving traditional Chinese medicine preparation. Comprising 20-40 parts of wine-treated zaocys dhumnade, 12-18 parts of caulis spatholobi, 5-10 parts of astragalus membranaceus, 6-11 parts of angelica sinensis, 3-9 parts of sculellaria barbata, 6-12 parts of lily, 8-14 parts of pericarpium trichosanthis, 4-10 parts of cacumen biotae, 22-26 parts of folium eriobotryae, 3-9 parts of selaginella tamariscina, 12-18 parts of felwort, 9-14 parts of radix ophiopogonis, 18-23 parts of sappan wood, 10-15 parts of corydalis tuber, 7-15 parts of prepared rehmannia root, 27-35 parts of campsis grandiflora and 18-30 parts of honey-fried licorice root. The Zaocys dhumnade pain-relieving traditional Chinese medicine preparation is prepared from wine-treated Zaocys dhumnade, caulis spatholobi, astragalus membranaceus, angelica sinensis, sculellaria barbata, lily, pericarpium trichosanthis, cacumen biotae and the like, has the effects of clearing away heat and toxic materials, replenishing qi and enriching blood, dispelling wind and removing obstruction in the meridians, activating blood, drying dampness and reducing phlegm and the like, can effectively relieve discomfort symptoms such as pain of the hand-foot syndrome and effectively improves the living quality of patients.

The present invention relates to the technical field of traditional Chinese medicine, and discloses a prescription for treating chronic atrophic gastritis, which is composed of the following raw materials: Fructus Aurantii 9-15 g, Magnolia officinalis 9-15 g, dried ginger 6-9 g, Codonopsis pilosula 15-30 g, Poria cocos 15-30 g, Pinellia ternata 9-15 g, Panax notoginseng powder 6-9 g, Hedyotis diffusa 15-30 g, Scutellaria barbata 9-15 g, and is composed of the following raw materials: Fructus Aurantii 12 g, dried ginger 6 g, Magnolia officinalis 12 g, Codonopsis pilosula 20 g, Poria cocos 15 g, Pinellia ternata preparata 12 g, Panax notoginseng powder 9 g, Scutellaria barbata 12 g, Hedyotis diffusa 15 g. The total effective rate of the treatment group (95.00%) was higher than that of the control group (72.50%) (P < 0.05); the levels of TNF-α, IL-2, and IL-6 in both groups after treatment were lower than those before treatment in the same group (P < 0.05); the levels of TNF-α, IL-2, and IL-6 in the treatment group after treatment were lower than those in the control group (P < 0.05).

The invention relates to the technical field of traditional Chinese medicine preparations, and discloses a traditional Chinese medicine composition for treating hepatocellular carcinoma and application thereof, and the traditional Chinese medicine composition comprises the following components in parts by mass: 8-12 parts of ginseng, 13-17 parts of astragalus membranaceus, 8-12 parts of angelica sinensis, 8-12 parts of rhizoma polygonati, 8-12 parts of curcuma zedoary, 18-22 parts of oldenlandia diffusa, 8-12 parts of edible tulip, 3-6 parts of liquorice, 10-15 parts of sculellaria barbata and 5-10 parts of ganoderma lucidum spore powder. In the composition, the ginseng, the astragalus membranaceus and other medicines can enhance the immunity of the organism and protect hepatocytes, the curcuma zedoary, the oldenlandia diffusa and other medicines can directly inhibit tumor growth, and the curcuma zedoary and the oldenlandia diffusa and other medicines cooperate with each other, so that the composition not only improves the physique of a patient, but also plays an anti-tumor role, and accords with the pathogenesis characteristics of deficiency of vital qi and accumulation of pathogenic toxin of liver cancer.

The invention discloses a traditional Chinese medicine composition for treating renal clear cell carcinoma as well as a preparation method and application thereof, and belongs to the technical field of medicines. The traditional Chinese medicine composition provided by the invention comprises ginseng, astragalus membranaceus, bighead atractylodes rhizome, poria cocos, sculellaria barbata, oldenlandia diffusa, curcuma zedoary, dogwood, glossy privet fruit and selfheal. The traditional Chinese medicine composition provided by the invention is scientific and reasonable in compatibility, and can strengthen body resistance to eliminate pathogenic factors, clear away heat and toxic materials, promote blood circulation to remove blood stasis and soften hardness to dissipate stagnation. Clinical experiment results show that the traditional Chinese medicine composition provided by the invention can be used for effectively treating the renal clear cell carcinoma, and the treatment effective rate is superior to that of targeted medicine sorafenib; the traditional Chinese medicine composition is safe to take, has no obvious toxic or side effect, and has excellent performance in the aspects of improving traditional Chinese medicine syndromes of patients, improving life quality and reducing tumor marker level. The invention provides a new thought and method for treating the clear cell renal carcinoma, and has remarkable clinical significance and important popularization value.

The invention belongs to the technical field of biological medicines, and relates to governor meridian powder and a preparation method thereof. The invention provides governor meridian powder. The governor meridian powder is prepared from the following powdery components: ginseng, coptis chinensis, obscured homalomena rhizome, cortex illicii, sulfur, berchemia sinica, peach kernel, safflower, lignum dalbergiae odoriferae, radix aucklandiae, garden balsam stem, lycopodium clavatum, myrrh, rhizoma atractylodis, radix clematidis, caulis spatholobi, sargentgloryvine stem, vernonia graveolens, entada phaseoloides, folium artemisiae argyi, sculellaria barbata, folium photiniae and liquorice. The governor meridian powder is used for governor meridian moxibustion, the governor meridian powder and ginger are sequentially laid on the back of a human body, and moxa is ignited for use. The governor meridian powder provided by the invention can improve the effective rate and improvement speed of governor meridian moxibustion.

The invention relates to the field of traditional Chinese medicine preparations and pharmaceutical science, and discloses a preparation method of white jade powder decoction, which comprises the following steps: (1) gradient directional extraction: a, mixing and extracting 15-30 parts of sculellaria barbata, 15-30 parts of oldenlandia diffusa, 6-9 parts of curcuma zedoary, 3-10 parts of ground beetle and 70-80% ethanol; b, mixing and decocting 9-30 parts of radix astragali, 6-12 parts of roasted rhizoma atractylodis macrocephalae, 5-10 parts of radix saposhnikoviae and a buffer solution; (2) mixing the two extracting solutions in the step (1) to construct a core-shell structure; (3) carrying out spray drying on the mixed solution to prepare a solid dispersion; and (4) performing enteric coating modification on the powder. Through scientific drug release kinetic analysis, the effect of optimizing the ratio and bioavailability of the effective components is achieved, and compared with the scheme of single-component drugs in the prior art, the defects that the absorption rate of the effective components is low and the drug effect is unstable are overcome. Therefore, the medicine can better exert the treatment effect in clinical application, and the medication experience of a patient is improved.

The invention provides a traditional Chinese medicine formula for preventing African swine fever, a preparation method and a feed composition. The traditional Chinese medicine formula is prepared from the following raw materials in parts by mass: 10 to 20 parts of radix rehmanniae, 6 to 12 parts of radix arnebiae seu lithospermi, 9 to 21 parts of cortex phellodendri, 10 to 19 parts of folium isatidis, 8 to 14 parts of fructus gardeniae, 6 to 12 parts of herba scutellariae barbatae, 6 to 12 parts of herba lobeliae chinensis, 7 to 18 parts of herba hedyotis diffusae, 8 to 18 parts of radix platycodonis, 6 to 12 parts of flos lonicerae and 3 to 10 parts of radix glycyrrhizae. The traditional Chinese medicine formula has a good prevention effect on African swine fever.